Recent Avenue to Cancer Prevention

Zsuzsanna Suba (Editor)
National Institute of Oncology, Department of Surgical and Molecular Tumor Pathology, Budapest, Hungary

Series: Cancer Etiology, Diagnosis and Treatments
BISAC: SCI055000

Clear

$179.00

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Details

This work presents some recent clinical, epidemiological and experimental data on the cancer preventive effect of healthy hormonal equilibrium. Insulin resistance-associated overproduction of peptide hormones, such as growth hormone, insulin and insulin-like growth factors, interacting simply with cell membrane receptors, have a proven tumor inducing capacity. Another group of hormones, including estrogens, thyroids and vitamin D, has both genomic intranuclear and non-genomic membrane-associated receptor signaling, thus they have complex roles in all basic cellular functions. Recent results suggest that defective synthesis of these latter hormones or alterations of their signal transduction pathways may thoroughly disturb metabolic processes, reproduction and the regulation of cell proliferation.

Primary cancer prevention based on the preservation or restoration of the hormonal and metabolic equilibrium of patients may be the main program of the anticancer fight in the 21st century. Moreover, in cases with diagnosed malignancy, we should cure the ill patients instead of their tumors. After surgical tumor removal, the achievement of hormonal and metabolic equilibrium restores the natural defense mechanisms of patients, which may help to stop tumor recurrence. (Nova Biomedical) (Imprint: Nova Biomedical )

Preface

Chapter 1. A long way from hyperestrogenism to estrogen deficiency as mediator of cancer risk in obesity. (Zsuzsanna Suba, National Institute of Oncology, Department of Surgical and Molecular Pathology, Budapest, Hungary)
Free Download Available

Chapter 2. Light exposure associated hormonal equilibrium is protective against cancer risk.
(Zsuzsanna Suba, National Institute of Oncology, Department of Surgical and Molecular Pathology, Budapest, Hungary)
Free Download Available

Chapter 3. Sexual dimorphism in obesity related cancer risk (Zsuzsanna Suba, National Institute of Oncology, Department of Surgical and Molecular Pathology, Budapest, Hungary)
Free Download Available

Chapter 4. Recovery of estrogen level in obese women is preventive against cancer. (Zsuzsanna Suba, National Institute of Oncology, Department of Surgical and Molecular Pathology, Budapest, Hungary)
Free Download Available

Chapter 5. Estrogen receptors are pivotal regulators of glucose uptake and energy expenditure. (Zsuzsanna Suba, National Institute of Oncology, Department of Surgical and Molecular Pathology, Budapest, Hungary)
Free Download Available

Chapter 6. Triple-negative breast cancer risk in women is increasing by the loss of estrogen supply or by defective estrogen signaling. (Zsuzsanna Suba, National Institute of Oncology, Department of Surgical and Molecular Pathology, Budapest, Hungary)
Free Download Available

Chapter 7. Role of ultraviolet-B irradiance and vitamin D in reducing risk of cancer. (William B. Grant1, Meis Moukayed2, Sunlight, Nutrition and Health Research Center, San Francisco, California, USA1, School of Arts and Sciences, American University in Dubai, Dubai, UAE2)
Free Download Available

Index

You have not viewed any product yet.